欧美成人免费全部观看天天性色,国产机精品视频a区,美女天天要操b天天要日b,在线手机成本人片无码免费,国产色婷婷精品综合在线手机播放,91高清免费国产自产,超清首页国产亚洲丝袜

About Us

Home > About Us> Company Introduction

Company Introduction

Company Profile

Xiamen OneClone Biotech Inc. was established in 2011 and is located in the National Innovation and Entrepreneurship Park of Xiamen Torch High-Tech Zone. The company is a high-tech enterprise founded by overseas returnees and recognized as a "Double Hundred Talent" enterprise by the Xiamen Municipal Government. The company has introduced leading high-tech talents from Singapore and the United States, specializing in the R&D, production, and sales of bioactive raw materials for diagnostic reagents.

The company is primarily dedicated to the R&D and production of antigens and antibodies for immunodiagnostics, including(but not limited to):

· Respiratory Infectious Diseases: eg.Natural/recombinant Mycoplasma pneumoniae, Chlamydia pneumoniae, Respiratory syncytial virus, Adenovirus, Influenza A/B, Parainfluenza virus, Human metapneumovirus, Rhinovirus, and Bordetella pertussis.

· Hand, Foot, and Mouth Disease 

· Hepatitis Virus 

· prenatal and perinatal screening 

· Mycobacterium tuberculosis 

· Helicobacter pylori 

· Immunization Efficacy Monitoring

· Animal/Pet Infectious Diseases

· Autoimmune Diseases

The products are characterized by high specificity, high sensitivity, and excellent stability, with quality meeting or exceeding comparable domestic and international products, and have gained broad recognition among diagnostic-reagent manufacturers.

With a strong focus on independent R&D and collaboration with research institutions such as Xiamen University, the company continuously develops new technologies and products. As a professional enterprise dedicated to the R&D and production of bioactive raw materials for diagnostic reagents, Xiamen OneClone Biotech is committed to advancing into the future, striving to provide high-quality bioactive materials for diagnostic reagent manufacturers and research institutions, fostering mutual success.


Contact 1

Contact 2

Contact 3

WeChat